Diligence memo · auto-generated · as of July 3, 2026

Kyan Health, Inc.

Kyan Health, Inc. looks fair against its niche peers and is quiet on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

Kyan Health, Inc. operates in Healthtech, based in ZOLLIKON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Kyan Health, Inc. has raised $11M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $11M on 2024-11-01.

Most recent recorded round closed around 2024-11-01.

Valuation (modeled)modeled

Provath models Kyan Health, Inc. at approximately $49M (range $14M–$97M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.16× the median modeled value of Series A Healthtech companies in 2022–2024 (190 peers) — value vs value, same stage and era. Within the normal band (116% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 20 mo ago; this sector typically re-raises about every 14 months.

Slightly overdue versus sector cadence.

Comparablesmixed

Capital scale ranks ahead of 71% of Healthtech peers (2138 compared).

Modeled value ranks above 62% of those peers.

Closest niche peers: Nayya Health, Inc., Nue Life Health Inc., W Health Studio, Inc., Avant-garde Health, Inc., Kinetik Healthcare Solutions, Inc.

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.